loadpatents
name:-0.021151065826416
name:-0.011584997177124
name:-0.0016329288482666
Davis; Claude Geoffrey Patent Filings

Davis; Claude Geoffrey

Patent Applications and Registrations

Patent applications and USPTO patent grants for Davis; Claude Geoffrey.The latest application filed is for "engineered endothelial cells expressing an ets transcription factor".

Company Profile
1.12.17
  • Davis; Claude Geoffrey - Auburn CA
  • Davis; Claude Geoffrey - San Mateo CA US
  • Davis; Claude Geoffrey - Burlingame CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Engineered Endothelial Cells Expressing An Ets Transcription Factor
App 20220204924 - Nolan; Daniel Joseph ;   et al.
2022-06-30
Engineered endothelial cells expressing an ETS transcription factor
Grant 10,961,509 - Nolan , et al. March 30, 2
2021-03-30
Neural cells expressing adenovirus E4ORF1, and methods of making and using the same
Grant 10,947,500 - Qiang , et al. March 16, 2
2021-03-16
Enhanced Gene Delivery Methods
App 20190127760 - Finnegan; Paul William ;   et al.
2019-05-02
Modified toxins
Grant 10,059,750 - Davis , et al. August 28, 2
2018-08-28
Methods And Compositions For Stem Cell Transplantation
App 20180214488 - Finnegan; Paul William ;   et al.
2018-08-02
Engineered Endothelial Cells Expressing An Ets Transcription Factor
App 20180195040 - Nolan; Daniel Joseph ;   et al.
2018-07-12
Biocompatible Implants Comprising Engineered Endothelial Cells
App 20170360988 - Ginsberg; Michael Daniel ;   et al.
2017-12-21
Neural Cells Expressing Adenovirus E4orf1, And Methods Of Making And Using The Same
App 20170137781 - Qiang; Liang ;   et al.
2017-05-18
Modified Toxins
App 20160009768 - Davis; Claude Geoffrey ;   et al.
2016-01-14
Modified toxins
Grant 8,470,314 - Davis , et al. June 25, 2
2013-06-25
Modified toxins
Grant 8,252,897 - Davis , et al. August 28, 2
2012-08-28
Compositions and methods for treating B-cell malignancies
Grant 8,067,011 - Davis , et al. November 29, 2
2011-11-29
Modified Toxins
App 20090221500 - Davis; Claude Geoffrey ;   et al.
2009-09-03
Modified Toxins
App 20090041797 - Davis; Claude Geoffrey ;   et al.
2009-02-12
Modified Diphtheria Toxins
App 20090010966 - Davis; Claude Geoffrey ;   et al.
2009-01-08
Production of a multimeric protein by cell fusion method
Grant 7,429,380 - Hori , et al. September 30, 2
2008-09-30
Compositions and methods for treating B-cell malignancies
App 20070269370 - Davis; Claude Geoffrey ;   et al.
2007-11-22
Production of a multimeric protein by cell fusion method
App 20040142430 - Hori, Nobuaki ;   et al.
2004-07-22
Production of a multimeric protein by cell fusion method
Grant 6,677,138 - Hori , et al. January 13, 2
2004-01-13
Epitope-driven human antibody production and gene expression profiling
App 20030092125 - Davis, Claude Geoffrey ;   et al.
2003-05-15
Production of a multimeric protein by cell fusion method
App 20030022291 - Hori, Nobuaki ;   et al.
2003-01-30
Production Of Multimeric Protein By Cell Fusion Method
App 20020098551 - Hori, Nobuaki ;   et al.
2002-07-25
Production of multimeric protein by cell fusion method
Grant 6,420,140 - Hori , et al. July 16, 2
2002-07-16
Production of a multimeric protein by cell fusion method
App 20020076763 - Hori, Nobuaki ;   et al.
2002-06-20
Epitope-driven Human Antibody Production And Gene Expression Profiling
App 20020029391 - DAVIS, CLAUDE GEOFFREY ;   et al.
2002-03-07
Production of a multimeric protein by cell fusion method
Grant 6,207,418 - Hori , et al. March 27, 2
2001-03-27
Production of a multimeric protein by cell fusion method
Grant 5,916,771 - Hori , et al. June 29, 1
1999-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed